Vaccination has become one of the most successful strategies in preventing infectious and non-infectious diseases. The rapid development, production, and distribution of influenza vaccines could potentially save millions of lives during a pandemic influenza, however, there are still many diseases for which vaccines are not available such as malaria, dengue, enterotoxigenic E. coli, and tuberculosis.
New vaccines and new delivery technology being developed in the next 10 years will fundamentally change prevention and treatment strategies amongst clinicians with a substantial impact on public health.
Our team of professionals has gained considerable experience in clinical trials with vaccines including development planning, centre acquisition and monitoring throughout the past 10 years.